跳至主要内容
临床试验/NCT04038164
NCT04038164已完成不适用

Dog-Assisted Therapy for Children and Adolescents With FASD: a Randomized Controlled Pilot Study

Hospital Universitari Vall d'Hebron Research Institute2 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2018年4月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
39
试验地点
2
主要终点
Change from baseline on Social skills at 3 months

研究概览

简要总结

The rationale of the present study was to evaluate the efficacy of DAT in children and adolescents with FASD in relation to its effects on social skills, internalized and externalized symptomatology and on severity of FASD symptoms. This objective was accomplished through a randomized controlled pilot study of DAT for children and adolescents with FASD.

详细描述

The rationale of this study was to evaluate the efficacy of Dog Assisted Therapy in children and adolescents with FASD. The investigators conducted a randomized, rater-blinded, controlled pilot trial in a cohort of 33 children and adolescents with FASD. Participants were randomly assigned either to DAT group (n=17) or Treatment as Usual (TAU control group) (n=16). The investigators evaluated changes on social skills, internalized and externalized symptomatology and on severity of FASD symptoms at pre-treatment and post-treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Rater-blinded

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with FASD between 6 and 18 years (FAS, pFAS or ARND)
  • With or without comorbidities
  • Stabilized doses of medication for at least 2 months before the study
  • Patients with borderline IQ or mental retardation.

排除标准

  • Patients who were not behaviorally stable
  • Patients that required hospitalization, day hospital or more intensive treatments.

研究组 & 干预措施

Dog-Assisted Therapy (DAT) and pharmacological treatment

Experimental

The DAT program comprised 12 manualized sessions and included two phases: 1) individual intervention (6 sessions) and 2) group activity (6 sessions). Patients participated in weekly sessions for about 3 months. Each session lasted 45 minutes. The groups were formed by 3-4 patients. Sessions included the participation of two certified therapy dogs, two technicians specialized in DAT and a psychologist. Participants in this group were visited by their psychiatrist in order to monitor their adherence to medications.

干预措施: Dog-Assisted Therapy and pharmacological treatment (Behavioral)

Treatment as usual (TAU, pharmacological treatment)

Active Comparator

Participants received their usual treatment. They were visited by their psychiatrist in order to monitor their adherence and continuation on medications as prescribed. Inclusion and exclusion criteria were the same as for the experimental group. Participants in the TAU group did not receive DAT sessions.

干预措施: Dog-Assisted Therapy and pharmacological treatment (Behavioral)

结局指标

主要结局

Change from baseline on Social skills at 3 months

时间窗: Pre-treatment (baseline) and post-treatment assessment (through study completion, at 3 months)

Social Skills Improvement System-Parent Form (SSIS-P). is a 79 items scale (Likert scale 0 to 4) measuring social skills and problem behaviors in children and adolescents as reported by their parents. In the Social Skills domain, the subscales are communication, cooperation, assertion, responsibility, empathy, engagement, and self-control. The Problem Behaviors domain includes internalizing and externalizing problems, bullying, hyperactivity/inattention and autism spectrum.

Change from baseline on Externalizing symptoms at 3 months

时间窗: Pre-treatment (baseline) and post-treatment assessment (through study completion, at 3 months)

Child Behavior Checklist (CBCL of Achenbach) parent version. to assess Internalizing and Externalizing Symptoms in patients between 4 and 18 years. The CBCL is a 113 item scale (Likert scale: 0-2) which assesses withdrawn symptoms, somatic complains, anxiety/depressive symptoms, thought problems, ADHD features, oppositional behavior and behavioral problems. Higher scores indicate more conduct problems.

Change from baseline FASD severity at 3 months

时间窗: Pre-treatment (baseline) and post-treatment assessment (through study completion, at 3 months)

Clinical Global Impression Scale for Severity(CGI-S Clinician). The Clinical Global Impression Scale for Severity (CGI-S): is a 7-point scale (1 = normal or not ill, and 7 = extremely ill) .

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验